Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns

被引:2
|
作者
Samuel, Sonia [1 ]
Michael, Mark [1 ]
Tadros, Micheal [2 ]
机构
[1] Albany Med Ctr, Dept Internal Med, Albany, NY 12208 USA
[2] Albany Med Ctr, Dept Gastroenterol & Hepatol, 43 New Scotland Ave, Albany, NY 12208 USA
关键词
Marijuana; cannabis; Endocannabinoid system; Side effects; Gastrointestinal disorders; ESOPHAGEAL SPHINCTER RELAXATIONS; INDUCED ACUTE-PANCREATITIS; IRRITABLE-BOWEL-SYNDROME; BODY-MASS INDEX; CROHNS-DISEASE; DOUBLE-BLIND; MARIJUANA USE; COMBINATION THERAPY; ANXIETY DISORDERS; MEGESTROL-ACETATE;
D O I
10.12998/wjcc.v11.i18.4210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cannabis, commonly known as marijuana, is a drug extracted from the Cannabis plant known for its psychotropic and medicinal properties. It has been used for healing purposes during ancient times, although its psychoactive components led to its restricted use in medicine. Nonetheless, cannabis is found to have modulatory effects on the endocannabinoid system exhibiting its medicinal role in the gastrointestinal (GI) system. Emerging animal and human studies demonstrate the influential effects of cannabis on a variety of GI diseases including inflammatory bowel disease, motility disorders and GI malignancies. It also has a regulatory role in GI symptoms including nausea and vomiting, anorexia, weight gain, abdominal pain, among others. However, both its acute and chronic use can lead to undesirable side effects such as dependency and addiction, cognitive impairment and cannabinoid hyperemesis syndrome. We will discuss the role of cannabis in the GI system as well as dosing strategies to help guide gastroenterologists to assess its efficacy and provide patient counseling before prescription of medical marijuana.
引用
收藏
页数:22
相关论文
共 47 条
  • [31] Primary care physicians' attitudes and knowledge regarding medical cannabis and willingness to prescribe it: the Israeli experience
    Adler, Limor
    Zacay, Galia
    Schonmann, Yochai
    Azuri, Joseph
    Yehoshua, Ilan
    Vinker, Shlomo
    Shani, Michal
    Heymann, Anthony D.
    Hoffman, Robert
    FAMILY PRACTICE, 2022, 39 (01) : 59 - 64
  • [32] Top Ten Tips Palliative Care Clinicians Should Know About Medical Cannabis
    Briscoe, Joshua
    Kamal, Arif H.
    Casarett, David J.
    JOURNAL OF PALLIATIVE MEDICINE, 2019, 22 (03) : 319 - 325
  • [33] Clostridium Difficile Infection and Inflammatory Bowel Disease: What Gastroenterologists and Surgeons Should Know
    Cojocariu, C.
    Trifan, A.
    Stoica, O.
    Chihaia, C. A.
    Stanciu, C.
    CHIRURGIA, 2014, 109 (05) : 579 - 583
  • [34] Should periodontists prescribe postoperative oral corticosteroids to control pain and swelling? A systematic review
    Wagner, Jennah C.
    Johnson, Thomas M.
    Gilbert, William A.
    CLINICAL ADVANCES IN PERIODONTICS, 2022, 12 (02) : 134 - 142
  • [35] Respiratory health effects of cannabis-How should we respond to liberalization of cannabis laws?
    Hancox, Robert J.
    RESPIROLOGY, 2024, 29 (04) : 277 - 279
  • [36] How should policymakers regulate the tetrahydrocannabinol content of cannabis products in a legal market?
    Hall, Wayne
    Leung, Janni
    Carlini, Beatriz H. H.
    ADDICTION, 2023, 118 (06) : 998 - 1003
  • [37] Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans
    Mohini Ranganathan
    Joao P. De Aquino
    Jose A. Cortes-Briones
    Rajiv Radhakrishnan
    Brian Pittman
    Savita Bhakta
    Deepak C. D’Souza
    Psychopharmacology, 2019, 236 : 3209 - 3219
  • [38] Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans
    Ranganathan, Mohini
    De Aquino, Joao P.
    Cortes-Briones, Jose A.
    Radhakrishnan, Rajiv
    Pittman, Brian
    Bhakta, Savita
    D'Souza, Deepak C.
    PSYCHOPHARMACOLOGY, 2019, 236 (11) : 3209 - 3219
  • [39] What Gastroenterologists Should Know About the Gray Market, Herbal Remedies, and Compounded Pharmaceuticals and Their Regulation by the Food and Drug Administration
    Ehrenpreis, Eli D.
    Kulkarni, Prasad
    Burke, Carol
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (05) : 642 - 646
  • [40] GPs and cannabis in France: should we ask our young patients about their use?
    Laporte, Catherine
    Hamma, Sarah
    Dupouy, Julie
    Kinouani, Sherazade
    Pautrat, Maxime
    Authier, Nicolas
    Llorca, Pierre-Michel
    Brousse, Georges
    Vorilhon, Philippe
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2016, 27 (125): : 120 - 129